Our research has two major limitations, the first being that our research is a small sample investigation, and the correlation between EGF and markers of inflammation in COVID‐19 has yet to be explored in more detail; we also lack longitudinal follow‐up results for patients with COVID‐19. The gene discussed is EGF; the disease is COVID-19.